Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies Inc (BWXT) delivers mission-critical nuclear components and technical services for government and commercial sectors worldwide. This dedicated news hub provides investors and industry professionals with authoritative updates directly from the company and verified sources.
Access real-time announcements including earnings reports, government contract awards, and R&D breakthroughs in nuclear manufacturing. Track developments across BWXT's core operations: precision component production for defense programs, radiopharmaceutical innovations, and environmental remediation projects.
Our curated feed simplifies monitoring of strategic partnerships, regulatory milestones, and technology advancements in nuclear operations. Bookmark this page for streamlined access to BWXT's official financial disclosures, facility updates, and leadership communications - all essential for understanding this specialized industrial leader.
BWX Technologies, Inc. (BWXT) is set to release its second quarter 2021 financial results on August 2, 2021, after the market closes. A conference call will follow at 5:00 p.m. EDT, allowing participants to join and access a supporting presentation online. BWXT, based in Lynchburg, Virginia, specializes in providing nuclear solutions across various sectors, employing approximately 6,700 individuals across 12 major sites in the U.S. and Canada. The company is involved in numerous joint ventures with the U.S. Department of Energy and NASA.
BWXT Medical Ltd. announced a long-term agreement with Boston Scientific to manufacture TheraSphere™ Y-90 Glass Microspheres, aimed at treating hepatocellular carcinoma (HCC). The deal includes substantial investment to automate production at BWXT's Ottawa facility, enhancing capacity to meet growing demand. This follows Boston Scientific's recent FDA PMA approval of TheraSphere, which increases patient access to this treatment. BWXT cautions that various risks may affect production and demand for TheraSphere.
BWX Technologies reported Q1 2021 revenue of $528 million, down 2.6% from $542 million in Q1 2020. Net income was $69.7 million ($0.73 per diluted share), a decrease from $75.5 million ($0.79 per diluted share) year-over-year. The Nuclear Operations Group faced a 5.1% revenue decline, while the Nuclear Power Group saw a 22% increase. The company generated $98.4 million in cash from operations, compared to a $6.4 million loss in Q1 2020, and declared a $0.21 dividend per share. BWXT reiterated 2021 guidance for revenue and non-GAAP EPS between $3.05 and $3.20.
BWX Technologies, Inc. (NYSE: BWXT) has enhanced its technical fellows initiative by selecting 25 new employees, recognizing their scientific and engineering contributions. The fellows, seen as senior technical leaders, will provide ongoing technical guidance and mentor future talent. This initiative aims to leverage expertise to strengthen workforce excellence and promote diversity in leadership. The program spans various business segments in the U.S. and Canada, focusing on areas like nuclear safety, automation, and engineering. BWXT is committed to fostering innovation and technical excellence.
BWX Technologies (NYSE: BWXT) has secured U.S. Naval Nuclear Propulsion Program contracts worth approximately $2.2 billion, including future options, for producing naval nuclear reactor components and fuel. This continues a long-standing partnership with the U.S. government spanning over 65 years. The contracts, initiated in 2021, will be fulfilled over an 8-year period across multiple facilities in Virginia, Ohio, and Indiana. The projects are vital for the Columbia and Virginia-class submarines, supporting U.S. strategic defense.
BWX Technologies, Inc. (BWXT) has announced a webcast to discuss its first quarter 2021 results on May 4, 2021, at 9:00 a.m. EDT. A press release detailing the results will follow after market close on May 3.
Listeners can join via www.bwxt.com/investors. Dial-in numbers for participants are (U.S.) 844-850-0542 and (International) 412-317-6014. A replay will be available on the BWXT website for a limited time.
BWX Technologies, Inc. (NYSE: BWXT) has successfully closed a $400 million offering of 4.125% senior notes due 2029. The Notes are guaranteed by its wholly owned subsidiaries. Proceeds will be utilized to redeem the outstanding 5.375% senior notes due 2026 and repay credit facility debt. Any remaining funds will be held in cash or short-term investments. The release includes forward-looking statements and cautions against undue reliance on them. Further risk factors can be found in BWXT's SEC filings.
BWX Technologies, Inc. (NYSE: BWXT) has secured a contract extension valued at up to $690 million from the U.S. Department of Energy (DOE) for environmental management work at the Portsmouth Gaseous Diffusion Plant. This extension, effective March 29, 2021, includes a one-year term with two additional six-month options. The contract involves decontamination, demolition, and ongoing environmental remediation at the site, which was operational from 1954 to 2001. BWXT expresses confidence in its capabilities, highlighting its extensive experience in supporting DOE's Environmental Management mission.
BWX Technologies, Inc. (NYSE: BWXT) continues its Nuclear Thermal Propulsion (NTP) development for NASA with a new $9.4 million contract awarded to its subsidiary, BWXT Advanced Technologies LLC. The contract focuses on nuclear fuel design and engineering, including the production and coating of fuel kernels, as well as reactor design. The work will be executed at several BWXT facilities with a team of over 50 employees. This contract builds on BWXT's ongoing efforts in space propulsion technology aimed at enabling crewed missions to Mars.
BWX Technologies, Inc. (NYSE: BWXT) has priced its offering of $400 million in 4.125% senior notes due 2029. The offering aims to redeem the outstanding 5.375% senior notes due 2026, utilizing the net proceeds, along with cash or borrowings. The completion of the notes offering is expected on April 13, 2021, subject to customary closing conditions. The notes are offered under Rule 144A and Regulation S and are not registered under the Securities Act. BWXT warns of potential risks and uncertainties related to the offering's success and market demand.
